Cargando…

Nosip is a potential therapeutic target in hepatocellular carcinoma cells

Nitric oxide synthase-interacting protein (Nosip) interacts with nitric oxide synthase (NOS) and regulates NO synthesis and release, which participates in various critical physiological and pathological processes. However, the role of Nosip in hepatocellular carcinoma (HCC) is unclear. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Junjie, Yang, Dandan, Huang, Zheng, Pan, Xueshan, Cao, Ruoxue, Lian, Chaoqun, Ma, Jia, Li, Yuyun, Wang, Zhiwei, Xia, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387614/ https://www.ncbi.nlm.nih.gov/pubmed/37529099 http://dx.doi.org/10.1016/j.isci.2023.107353

Ejemplares similares

The Ubiquitin E3 Ligase NOSIP Modulates Protein Phosphatase 2A Activity in Craniofacial Development
por: Hoffmeister, Meike, et al.
Publicado: (2014)

Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation
por: Wu, Linhui, et al.
Publicado: (2022)

ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCsNOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells
por: Bian, Meng, et al.
Publicado: (2023)

ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma
por: Gao, Junjie, et al.
Publicado: (2022)

Nitidine chloride suppresses NEDD4 expression in lung cancer cells
por: Zhang, Jing, et al.
Publicado: (2020)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
por: He, Zehua, et al.
Publicado: (2023)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
por: Li, Chengzhang, et al.
Publicado: (2020)

E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma
por: Lv, Yi, et al.
Publicado: (2017)

Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma
por: Zhang, Junyong, et al.
Publicado: (2016)

Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
por: Gao, Jian, et al.
Publicado: (2021)

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
por: Loong, Herbert H, et al.
Publicado: (2014)

Sgo1 is a potential therapeutic target for hepatocellular carcinoma
por: Wang, Lyu-Han, et al.
Publicado: (2015)

Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma
por: Kiruthiga, Chandramohan, et al.
Publicado: (2020)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma
por: Liang, Xiao-Dong, et al.
Publicado: (2014)

Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
por: Yang, Heng, et al.
Publicado: (2021)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

Screening therapeutic targets of ribavirin in hepatocellular carcinoma
por: Xu, Chen, et al.
Publicado: (2018)

Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2017)

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
por: Tan, Wenliang, et al.
Publicado: (2018)

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma
por: Liu, Hao, et al.
Publicado: (2015)

TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance
por: Xia, Shunjie, et al.
Publicado: (2021)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma
por: Fu, Xiaowei, et al.
Publicado: (2018)

Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice
por: Qi, Shibo, et al.
Publicado: (2014)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
por: Gong, Jun, et al.
Publicado: (2020)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
por: Lee, Carol, et al.
Publicado: (2019)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
por: Dimri, Manali, et al.
Publicado: (2020)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

YES, a novel therapeutic target in hepatocellular carcinoma
por: Lapouge, Marjorie, et al.
Publicado: (2022)

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
por: Elmas, Abdulkadir, et al.
Publicado: (2022)

FXYD6: a novel therapeutic target toward hepatocellular carcinoma
por: Gao, Qian, et al.
Publicado: (2014)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
por: Zhang, B, et al.
Publicado: (2013)

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
por: Xia, Haoming, et al.
Publicado: (2021)

KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
por: Gao, Chao, et al.
Publicado: (2022)

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma
por: Zhou, Dong-Sheng, et al.
Publicado: (2015)

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
por: Tsirulnikov, Kirill, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tvc3bcj6dfjr4tl3uhrjpgfh1r